JNJ-17166864

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-17166864, covering 2015-04-29 to 2015-04-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in Adults [Phase 2]